Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block
NCT ID: NCT02144766
Last Updated: 2014-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
40 participants
INTERVENTIONAL
2014-04-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ropivacaine Though Laterosternal Catheters After Cardiac Surgery
NCT01196767
Serratus Anterior Plane Block for Management of Post Thoracotomy Pain
NCT04258436
Caudal Ropivacaine With or Without Dexmedetomidine for Post Operative Analgesia
NCT05979558
Effects of Methylprednisolone Plus Ropivacaine Infiltration Before Wound Closure on Laminoplasty or Laminectomy
NCT04493463
Administration of Ropivacaine by Bi-laterosternal Multiperforated Catheters Placed Before a Sternotomy for Cardiac Surgery
NCT04495504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine
caudal block with 1 ml/kg of ropivacaine 0.2%
ropivacaine
caudal block with 1 ml/kg of ropivacaine 0.2%
saline
caudal block with 1 ml/kg of saline
saline
caudal block with 1 ml/kg of saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ropivacaine
caudal block with 1 ml/kg of ropivacaine 0.2%
saline
caudal block with 1 ml/kg of saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Year
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Si-Qin Chen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Si-Qin Chen
attending doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xinhua Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
060717
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.